位置:成果数据库 > 期刊 > 期刊详情页
Effects of scutellarin on PKG in HCMECs after hypoxia roxygenation
  • ISSN号:1000-3002
  • 期刊名称:《中国药理学与毒理学杂志》
  • 时间:0
  • 分类:R285[医药卫生—中药学;医药卫生—中医学]
  • 作者机构:School of Pharmaceutical Science & Yunnan Key Laboratory of Pharmacology for Natural Products,Kunming Medical University, First Affiliated Hospital of Kunming Medical University, Shanghai Institute of Materia Medica,Chinese Academy of Sciences
  • 相关基金:The project supported by National Natural Science Foundation of China(30960450,81373964,81173110and 81402991);Yunnan Provincial Science and Technology Department(2011FA022,2014FA010,2014IA033and 2014BC012);Shanghai Science&Technology; Support Program(13431900401);National Science&Technology; Major Project of China(2014ZX09301-306-03)
中文摘要:

OBJECTIVE This study discusses the effects of scutellarin(SCU),which is one of effective component of Erigeron breviscapus(Vant.)Hand-Mazz,on cGMP dependent protein kinase(PKG)in human cardiac microvascular endothelial cells(HCMECs)after hypoxia roxygenation(HR).METHODS Based on a model of HCMECs cells with HR injury,cell viability is examined by MTT assay.Protein expression of PKG is analyzed by Western blotting and its enzyme activity is investigated by ELISA technology.RESULTS The results of MTT assay- indicate that SCU(1,10μmol·L1)could protect HCMECs against HR injury.SCU(0.1,1 and 10μmol·L-1)canenhance PKG-I expression in control and HR injury cells.Furthermore,SCU(1,10μmol·L-1 significantly increase PKG activity in control cells(P<0.01),and also SCU(100μmol·L-1)appears similar on enzyme activity in HR injury cells(P <0.05).CONCLUSION SCU appears protective effects on endothelial cells against HR damage.While its mechanisms may be related to the influence of SCU on PKG activity in HCMECs.

英文摘要:

OBJECTIVE This study discusses the effects of scutellarin(SCU),which is one of effective component of Erigeron breviscapus(Vant.)Hand-Mazz,on cGMP dependent protein kinase(PKG)in human cardiac microvascular endothelial cells(HCMECs)after hypoxia roxygenation(HR).METHODS Based on a model of HCMECs cells with HR injury,cell viability is examined by MTT assay.Protein expression of PKG is analyzed by Western blotting and its enzyme activity is investigated by ELISA technology.RESULTS The results of MTT assay- indicate that SCU(1,10μmol·L1)could protect HCMECs against HR injury.SCU(0.1,1 and 10μmol·L-1)canenhance PKG-I expression in control and HR injury cells.Furthermore,SCU(1,10μmol·L-1 significantly increase PKG activity in control cells(P<0.01),and also SCU(100μmol·L-1)appears similar on enzyme activity in HR injury cells(P <0.05).CONCLUSION SCU appears protective effects on endothelial cells against HR damage.While its mechanisms may be related to the influence of SCU on PKG activity in HCMECs.

同期刊论文项目
同项目期刊论文
期刊信息
  • 《中国药理学与毒理学杂志》
  • 北大核心期刊(2011版)
  • 主管单位:军事医学科学院
  • 主办单位:军事医学科学院毒物药物研究所 中国药理学会 中国毒理学会
  • 主编:张永祥
  • 地址:北京市海淀区太平路27号
  • 邮编:100850
  • 邮箱:cjpt518@163.com
  • 电话:010-68276743
  • 国际标准刊号:ISSN:1000-3002
  • 国内统一刊号:ISSN:11-1155/R
  • 邮发代号:82-140
  • 获奖情况:
  • 国内外数据库收录:
  • 美国化学文摘(网络版),英国农业与生物科学研究中心文摘,波兰哥白尼索引,荷兰文摘与引文数据库,荷兰医学文摘,美国剑桥科学文摘,日本日本科学技术振兴机构数据库,中国中国科技核心期刊,中国北大核心期刊(2004版),中国北大核心期刊(2008版),中国北大核心期刊(2011版),中国北大核心期刊(2014版),中国北大核心期刊(2000版)
  • 被引量:9749